ASCIA Education Projects

In 2020-2021 ASCIA will focus on developing, updating and promoting the following educational resources and webpages:

ASCIA Anaphylaxis projects | ASCIA Food Allergy projects | ASCIA Respiratory/Insect Allergy projects | ASCIA Drug (Medication) Allergy projectsASCIA Skin/Allergy projects | ASCIA Immunodeficiency projects | ASCIA Testing and Telehealth resources | ASCIA COVID-19 resources  

In 2020 the ASCIA team has been working with ASCIA members to update and develop more accessible, consistent and evidence based resources, education and training than in previous years. Due to many challenges in 2020 we believe that this work is now more important than ever, to support ASCIA members, their patients/carers, other health professionals and the community. 

In 2020 there were more than:

  • 20 new ASCIA resources developed (as listed below)
  • 40 ASCIA resources updated (as listed below)
  • 4,500 e-newsletters sent each month
  • 100,000 ASCIA e-training course registrations
  • 1.9 million ASCIA website visits
  • 3.3 million ASCIA website pageviews

ASCIA Anaphylaxis projects 

The following recently completed resources will be promoted in 2021:

The following projects are scheduled to be completed in early 2021:

  • New ASCIA anaphylaxis refresher e-training, a short course for trainers, schools, early childhood education/care (ECEC) and community - Content has been finalised and the course is expected to be available in March 2021.

ASCIA Food Allergy projects 

The following recently completed resources will be promoted in 2021:

The following projects are scheduled to be completed in early 2021:

  • New ASCIA Position Paper Oral Immunotherapy (OIT) for Food Allergy - Content is under review.
  • New ASCIA Fast Facts Oral Immunotherapy (OIT) for Food Allergy - Content is under review.
  • Updated ASCIA Food Allergy e-training and reference list - Content is under review and course completion is expected by March 2021. 
  • New ASCIA Cow's Milk Allergy Position Paper (for health professionals) - Completion is expected by April 2021.
  • New Oral Allergy (Pollen Food) Syndrome patient information - Completion is expected by April 2021.

ASCIA Respiratory/Insect Allergy projects 

The following recently completed resources will be promoted in 2021:

The following projects are scheduled to be completed in 2021 (subject to funding):

  • New ASCIA Sublingual Immunotherapy (SLIT) treatment plan
  • Updated ASCIA Allergen Immunotherapy e-training for health professionals
  • Updated ASCIA Allergen Immunotherapy training slides
  • New ASCIA Position Paper on Chronic Rhinosinusitis with Nasal Polyps
  • Updated ASCIA Allergic Rhinitis e-training for health professionals
  • Updated ASCIA Allergic Rhinitis training slides 

ASCIA Drug (Medication) Allergy projects 

The following recently completed resources will be promoted in 2021:

The following project is scheduled to be completed in early 2021:

  • New ASCIA Cephalosporin Allergy Consensus Statement - Content is in final stage of review.

ASCIA Skin/Allergy projects 

The following resources will be promoted in 2021:

The following projects are scheduled to be completed in 2021 (subject to funding):

ASCIA Immunodeficiency projects 

The following will be promoted in 2021:

The following projects are scheduled to be completed in 2021 (subject to funding):

ASCIA Testing and Telehealth resources 

The following recently completed resources will be promoted in 2021:

The following projects are scheduled to be completed in 2021:

  • Updated ASCIA Position Paper - Unorthodox Testing and Treatment for Allergic Disorders 
  • New ASCIA Fast Facts - Unorthodox Testing and Treatment for Allergic Disorders

ASCIA COVID-19 resources 

The following recently completed resources will be promoted in 2021:

The following project is scheduled to be completed in 2021:

  • Information about COVID-19 vaccines and possible allergic reactions

Content updated January 2021              

Mod ASCIA Member
Donate to AIFA
go to NAS website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.